Healthcare Associated Infection Clinical Trial
Official title:
Evaluating Antibiotic Stewardship and Healthcare-associated Infections Surveillance Assisted by Computer in the University Hospital of Nancy
Antibiotic resistance is one of the most pressing health threats that mankind faces now and in the coming decades. Antibiotic resistance leads to longer hospital stays, higher medical costs and increased mortality. In order to tackle antibiotic resistance, a computerized-decision support system (CDSS) facilitating antibiotic stewardship and an electronic surveillance software (ESS) facilitating infection prevention and control activities will implement in our tertiary care university hospital. The investigators conduct a pragmatic, prospective, single-centre, before-after uncontrolled study with an interrupted time-series analysis 12 months before and 12 months after the introduction of the CDSS for antibiotic stewardship (APSS) and ESS for infection surveillance (ZINC). APSS and ZINC will assist respectively the antibiotic stewardship and the infection prevention and control teams of Nancy University Hospital (France). The investigators will evaluate the impact of the CDSS/ESS on the antibiotic use in adult (≥ 18 years) inpatients (hospitalised ≥ 48h). The primary outcome is the prescription rate by all healthcare professionals from the hospital of all systemic antibiotics expressed in defined daily doses/1 000 patients/month. Concurrently, the investigators will assess the safety of the intervention, its impact on the appropriateness of antibiotic prescriptions and on additional precautions (isolation precautions) as recommended in guidelines, and on bacterial epidemiology (multidrug-resistant bacteria and Clostridioides difficile infections) in the hospital. Finally, the investigators will evaluate the users' satisfaction and the cost of this intervention from the hospital perspective.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05589727 -
Application of Ventilator-Associated Events (VAE) in Ventilator-Associated Pneumonia (VAP) Notified in Brazil
|
||
| Completed |
NCT04873557 -
Copper Use as Protection Against Antimicrobial Resistance in the ICU
|
N/A | |
| Completed |
NCT03843021 -
Ventricular Assist Device (VAD) Infection Prevention Survey
|
||
| Recruiting |
NCT04579094 -
Prevalence and Risk Factors for the Carriage of Bacteria and Clostridioid in Elderly Dependent Persons
|
||
| Recruiting |
NCT04192435 -
Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery
|
Phase 4 | |
| Recruiting |
NCT06216080 -
Dynamic Full-Field Optical Coherence Tomography for Structural and Microbiological Characterization of Central Venous Catheter-deposited Biofilm in Critically Ill Patients
|
||
| Enrolling by invitation |
NCT03924934 -
Community-associated Highly-Resistant Enterobacterales
|
||
| Recruiting |
NCT06379139 -
Dynamic Full-field Optical Coherence Tomography for Structural and Microbiological Characterization of Endotracheal Tube Biofilm in Critically Ill Patients
|
||
| Recruiting |
NCT06155747 -
Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
|
||
| Completed |
NCT03349268 -
Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection
|
N/A | |
| Completed |
NCT04053257 -
Effect of Video Camera Monitoring Feedback on Hand Hygiene Compliance and Infections in NICU
|
N/A | |
| Not yet recruiting |
NCT03189043 -
Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections
|
Phase 2 | |
| Completed |
NCT05797818 -
Red Light Photobiomodulation and Topical Disinfectants
|
Phase 1/Phase 2 | |
| Terminated |
NCT03361085 -
Modular Prevention Bundle for Non-ventilator-associated Hospital-acquired Pneumonia (nvHAP)
|
N/A | |
| Completed |
NCT04770597 -
Monitors to Improve Indoor Carbon Dioxide (CO2) Concentrations in the Hospital
|
N/A | |
| Recruiting |
NCT05612672 -
Evaluation of GeoHAI Implementation
|
N/A | |
| Completed |
NCT02605499 -
Ultra Violet-C Light Evaluation as an Adjunct to Removing Multi-Drug Resistant Organisms (UVCLEAR-MDRO)
|
N/A | |
| Completed |
NCT04676581 -
Risk Benefit Ratio of Hirudotherapy: Retrospective Single-center Study of 37 Cases Over a Period of 9 Years
|
||
| Recruiting |
NCT05979545 -
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
|
Phase 4 | |
| Active, not recruiting |
NCT04312243 -
NO Prevention of COVID-19 for Healthcare Providers
|
Phase 2 |